A selected reaction monitoring (SRM)-based method for absolute quantification of Aβ38, Aβ40, and Aβ42 in cerebrospinal fluid of Alzheimer's disease patients and healthy controls

Cerebrospinal fluid (CSF) biomarkers for Alzheimer’s disease (AD) are increasingly used in research centers, clinical trials, and clinical settings. However, their broad-scale use is hampered by lack of standardization across analytical platforms and by interference from binding of amyloid-beta (Abeta) to matrix proteins as well as self-aggregation. Here, we report on a matrix effectresistant method for the measurement of the AD-associated 42 amino acid species of Abeta (Abeta42), together with Abeta40 and Abeta38 in human CSF based on mass spectrometric quantification using selected reaction monitoring (SRM). Samples were prepared by solid-phase extraction and quantification was performed using stable-isotope labeled Abeta peptides as internal standards. The diagnostic performance of the method was evaluated on two independent clinical materials with research volunteers who were cognitively normal andADpatients with mild to moderate dementia. Analytical characteristics of the method include a lower limit of quantification of 62.5 pg/mL for Abeta42 and coefficients of variations below 10%. In a pilot study on AD patients and controls, we verified disease-association with decreased levels of Abeta42 similar to that obtained by ELISA and even better separation was obtained using the Abeta42/Abeta40 ratio. The developed assay is sensitive and is not influenced by matrix effects, enabling absolute quantification of Abeta42, Abeta40, and Abeta38 in CSF, while it retains the ability to distinguish AD patients from controls. We suggest this SRM-based method for Abeta peptide quantification in human CSF valuable for clinical research and trials.

PANNEE Josef;  PORTELIUS Erik;  OPPERMANN Madalina;  ATKINS Alan;  HORNSHAW Martin;  ZEGERS Ingrid;  HÖJRUP Peter;  MINTHON Lennart;  HANSSON Oskar;  ZETTERBERG Henrik;  BLENNOW Kaj;  GOBOM Johan; 

2013-07-30

IOS PRESS

JRC73862

1387-2877,   

http://iospress.metapress.com/content/d39530n6v88742t1/?genre=article&issn=1387-2877&volume=33&issue=4&spage=1021,    https://publications.jrc.ec.europa.eu/repository/handle/JRC73862,   

10.3233/JAD-2012-121471,